A. Nabar et al., Isoproterenol to evaluate resumption of conduction after right atrial isthmus ablation in type I atrial flutter, CIRCULATION, 99(25), 1999, pp. 3286-3291
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-After radiofrequency (RF) ablation of atrial flutter (AFL), the
demonstration of bidirectional isthmus conduction (BIC) block is considered
the hallmark of a successful procedure. The purpose of our study was to te
st the persistence of BIC block after isoproterenol administration and to e
valuate the importance of this finding with regard to AFL recurrences.
Methods and Results-RF ablation of AFL was performed in 44 consecutive pati
ents with type I AFL by linear ablation of the posterior isthmus (n=29 pati
ents), septal isthmus (n=4 patients), or both right atrial (RA) isthmi (n=1
1 patients). The procedural end point was complete BIC block and noninducib
ility of AFL. In case of noninducibility and apparent BIC block, the pacing
protocol was repeated under isoproterenol infusion (1 to 3 mu g/min). Reve
rsal of apparent BIC block occurred in 7 (15.9%) of 44 patients. Six patien
ts had bidirectional and 1 had unidirectional resumption of isthmus conduct
ion. Counterclockwise AFL could be reinduced in 4 of these patients. Two to
24 (median, 4) additional RF applications were required to achieve permane
nt BIC block. At a mean follow-up of 7.3+/-7.6 months (range, 2 to 31 month
s), 2 (4.5%) of 44 patients had AFL recurrences.
Conclusions-Partial linear RF ablation could possibly aggravate preexisting
nonuniform anisotropic conduction in the RA isthmus, resulting in profound
conduction slowing and apparent BIC block. Isoproterenol can unmask appare
nt BIC block, thus providing an opportunity to assess the possibility of re
versal of BIC block and completeness of isthmus ablation during the same pr
ocedure. The low incidence (4.5%) of AFL recurrences at follow-up suggests
that noninducibility and BIC block under isoproterenol infusion may be a be
tter end point for successful AFL ablation.